Ai‐Ming Yu

8.9k citations
160 papers · 6.9k · 3 hit papers · h-index 49

Impact in

  • Pharmacology top 0.05%
    • Pharmacogenetics and Drug Metabolism
    • MicroRNA in disease regulation
    • Cancer-related molecular mechanisms research

Papers in

    • RNA Interference and Gene Delivery 35
    • RNA modifications and cancer 34
    • RNA and protein synthesis mechanisms 11
    • MicroRNA in disease regulation 39
    • Cancer, Hypoxia, and Metabolism 11

Ai‐Ming Yu

154 papers receiving 6.8k citations

Ai‐Ming Yu's Hit Papers

RNAi-Based Therapeutics and Novel RNA Bioengineering Technologies 2022 · 188 citations
1880+4+8Years since publication100200300400

Peers

Ai‐Ming Yu
Comparison fields: 5 of 136
  • Pharmacology 1.5k
  • Cancer Research 1.8k
  • Oncology 1.5k
  • Molecular Biology 3.5k
  • Biological Psychiatry 97
Replace Christopher E. Goldring with:
Christopher E. Goldring United Kingdom
Cheng Huang China
Xinxin Ding United States
James D. Yager United States
Lorne J. Hofseth United States
Peter Kubatka Slovakia
Ryuichi Kato Japan
Denis M. Grant Canada
Derek J. Parks United States
Kimihiko Satoh Japan
Ai‐Ming Yu relative to Christopher E. Goldring United Kingdom Christopher E. Goldring's profile →
Citations per field
00.5×1.5×2.4×
Christopher E. Goldring · 1×
Citations per year

Countries citing papers authored by Ai‐Ming Yu

Since Specialization
Citations

This map shows the geographic impact of Ai‐Ming Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ai‐Ming Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ai‐Ming Yu more than expected).

Fields of papers citing papers by Ai‐Ming Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ai‐Ming Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ai‐Ming Yu. The network helps show where Ai‐Ming Yu may publish in the future.

Co-authors

The 25 scholars most cited alongside Ai‐Ming Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ai‐Ming Yu Line = papers co-authored together Ai‐Ming Yu links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 160 papers — load more, or switch the sort, to bring in the rest.

#Work
1
ABC Transporters in Multidrug Resistance and Pharmacokinetics, and Strategies for Drug Development
Hit paper breakdown →
2014463
2
RNA Drugs and RNA Targets for Small Molecules: Principles, Progress, and Challenges
Hit paper breakdown →
2020281
3 2009258
4 2019244
5 2009214
6
RNAi-Based Therapeutics and Novel RNA Bioengineering Technologies
Hit paper breakdown →
2022188
7 2012142
8 2003142
9 2004133
10
2003131
11
Comparative contribution to dextromethorphan metabolism by cytochrome P450 isoforms in vitro: can dextromethorphan be used as a dual probe for both CTP2D6 and CYP3A activities?
2001123
12 2010121
13 2018120
14 2005118
15 2005111
16 2003101
17 200398
18 200497
19 201193
20
200392

About Ai‐Ming Yu

Ai‐Ming Yu is a scholar working on Molecular Biology, Cancer Research, Oncology, Pharmacology and Pulmonary and Respiratory Medicine, having authored 160 papers that have together received 6.9k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (39 papers), RNA Interference and Gene Delivery (35 papers), RNA modifications and cancer (34 papers), Pharmacogenetics and Drug Metabolism (34 papers), Drug Transport and Resistance Mechanisms (26 papers), Cancer, Hypoxia, and Metabolism (11 papers), RNA and protein synthesis mechanisms (11 papers) and Neurotransmitter Receptor Influence on Behavior (9 papers). The work is most often cited by research in Pharmacology (1.5k citations), Cancer Research (1.8k citations), Oncology (1.5k citations), Molecular Biology (3.5k citations) and Biological Psychiatry (97 citations). Ai‐Ming Yu has collaborated with scholars based in United States, China and Switzerland. Frequent co-authors include Frank J. Gonzalez, Young Hee Choi, Mei‐Juan Tu, Jeffrey R. Idle, Kristopher W. Krausz, Robert L. Haining, A Küpfer, Gavin M. Traber, Pui Yan Ho and Marilyn E. Morris. Their work appears in journals such as Drug Metabolism and Disposition, Acta Pharmaceutica Sinica B, Journal of Pharmacology and Experimental Therapeutics, Biochemical Pharmacology and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact